vincamine
Selected indexed studies
- Vincamine, from an antioxidant and a cerebral vasodilator to its anticancer potential. (Bioorg Med Chem, 2023) [PMID:37579526]
- Vincamine as an agonist of G-protein-coupled receptor 40 effectively ameliorates diabetic peripheral neuropathy in mice. (Acta Pharmacol Sin, 2023) [PMID:37580494]
- Vincamine ameliorates hepatic fibrosis via inhibiting S100A4-mediated farnesoid X receptor activation: based on liver microenvironment and enterohepatic circulation dependence. (Br J Pharmacol, 2025) [PMID:39940076]
_Worker-drafted node — pending editorial review._
Connections
vincamine helps
Sources
- Vincamine, from an antioxidant and a cerebral vasodilator to its anticancer potential. (2023) pubmed
- Vincamine as an agonist of G-protein-coupled receptor 40 effectively ameliorates diabetic peripheral neuropathy in mice. (2023) pubmed
- Vincamine ameliorates hepatic fibrosis via inhibiting S100A4-mediated farnesoid X receptor activation: based on liver microenvironment and enterohepatic circulation dependence. (2025) pubmed
- Evaluation of vincamine against Acetylcholinesterase enzyme. (2022) pubmed
- Vincamine Mitigates Methotrexate-Induced Liver Fibrosis Model. (2025) pubmed
- Preventing Morphine-Seeking Behavior through the Re-Engineering of Vincamine's Biological Activity. (2020) pubmed
- Vincamine, an active constituent of Vinca rosea ameliorates experimentally induced acute lung injury in Swiss albino mice through modulation of Nrf-2/NF-κB signaling cascade. (2022) pubmed
- Vincamine alleviates intrahepatic cholestasis in rats through modulation of NF-kB/PDGF/klf6/PPARγ and PI3K/Akt pathways. (2024) pubmed
- A Review on Exploring the Potential of Vincamine and Melatonin as an Effective Anti-depressant Agent. (2024) pubmed
- Vincamine Ameliorates Epithelial-Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis in Rats; Targeting TGF-β/MAPK/Snai1 Pathway. (2023) pubmed